AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

Clinical trial NCT04145232 · UNKNOWN

Trial details

NCT number: NCT04145232
Sponsor: Ardigen
Status: UNKNOWN
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer Neoepitopes Neoantigens Immunotherapy Next Generation Sequencing (NGS)Personalized Neoantigen Cancer Vaccine

Start date: 2019-06-13
Primary completion: 2020-10-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.